Not recruiting
Haematological malignancy+1
Not recruitingStudy of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia
InvestigationalNo placebo
Study of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia
InvestigationalNo placebo
- Disease:Haematological malignancyChronic myelomonocytic leukaemia
- Substances:AZD2962
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:AZD2962
